Antibody Therapy of Hypercholesterolemia

Introduction There is now a new way to treat hypercholesterolemia,using a monoclonal antibody(Evolocumab)that binds to and inhibits PCSKA9.Most physicians know the term PCSK9but have no idea what PCSK9stands for(including me).My purpose for writing this editorial is to educate myself on what PCSK9is and what it does.My hope is that I can perhaps educate those reading this document as well.